Determination of Predictive Value of Echography Doppler Abnormalities
NCT00714909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2011-02-23
Summary
In order to avoid to use a traumatic and iatrogenic examen (phlebography), the purpose of the study is to validate echography doppler in the diagnosis of asymptomatic related catheter related thrombosis.
Conditions
- Breast Cancer
- Upper Extremity Deep Vein Thrombosis, Secondary
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Philippe M Debourdeau, MD · Saint-Louis Hospital, Paris, France
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2011-11-30
- Completion
- 2012-05-31
Countries
- France
Study Locations
More Related Trials
-
Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema
NCT01599039 ·Status: COMPLETED
-
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
NCT05726604 ·Status: UNKNOWN ·Phase: NA
-
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
NCT00071357 ·Status: COMPLETED
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Digital Breast Tomosynthesis in Younger Symptomatic Women
NCT01241981 ·Status: COMPLETED
-
Accuracy of Deep Inferior Epigastric Artery Perforator Mapping - Color Doppler Ultrasound Versus CT Angiography
NCT05687006 ·Status: COMPLETED ·Phase: NA
-
Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity
NCT02994225 ·Status: COMPLETED ·Phase: NA
-
Angiogenesis in Early Breast Cancer for Prognosis Prediction
NCT00599105 ·Status: COMPLETED ·Phase: NA
-
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
NCT02850302 ·Status: COMPLETED ·Phase: NA
-
Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy
NCT02032563 ·Status: UNKNOWN ·Phase: PHASE2
-
Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast Cancer
NCT05068999 ·Status: UNKNOWN
-
Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
NCT03580837 ·Status: UNKNOWN
-
Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer
NCT01837563 ·Status: TERMINATED
-
Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound
NCT01963624 ·Status: COMPLETED
-
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT03729115 ·Status: RECRUITING ·Phase: NA
-
Breast Cancer and Chemo-amennorhea
NCT01867229 ·Status: COMPLETED
-
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
NCT04799535 ·Status: RECRUITING
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
NCT05550090 ·Status: RECRUITING
-
Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer
NCT02575612 ·Status: COMPLETED ·Phase: NA
-
CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study
NCT05797129 ·Status: COMPLETED
-
Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy
NCT05141279 ·Status: UNKNOWN
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
Polymorphism Interaction to Predict Bevacizumab Efficacy
NCT01935102 ·Status: COMPLETED